Showing results (301-310 of 468) with videos related to

Sort By:
Pageof 47
JHEP Reports : Innovation in Hepatology|June 26, 2023
Long-term follow-up of patients discontinuing bulevirtide treatment upon long-term HDV-RNA suppressionMathias Jachs, Marlene Panzer, Lukas Hartl, et al.
Plos One|January 7, 2016
Conversion from Tacrolimus to Cyclosporine A Improves Glucose Tolerance in HCV-Positive Renal Transplant RecipientsAmmon Handisurya, Corinna Kerscher, Andrea Tura, et al.
Liver Cancer|June 14, 2019
Association of Platelet Count and Mean Platelet Volume with Overall Survival in Patients with Cirrhosis and Unresectable Hepatocellular CarcinomaBernhard Scheiner, Martha Kirstein, Sabine Popp, et al.
Advances in Medical Sciences|March 10, 2022
Splenectomy ameliorates portal pressure and anemia in animal models of cirrhotic and non-cirrhotic portal hypertensionPhilipp Schwabl, Berit Anna Seeland, Florian Riedl, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|September 17, 2020
Recent outbreaks of severe hepatitis A virus infections in ViennaDavid Bauer, Anna Farthofer, David Chromy, et al.
Wiener Klinische Wochenschrift|September 29, 2023
ELIMINATE: a PCR record-based macroelimination project for systematic recall of HCV-RNA-positive persons in AustriaCaroline Schwarz, David Bauer, Livia Dorn, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|November 2, 2017
ePTFE-TIPS vs repetitive LVP plus albumin for the treatment of refractory ascites in patients with cirrhosisTheresa Bucsics, Sophie Hoffman, Johanna Grünberger, et al.
Oncotarget|March 9, 2018
Impact of glutathione peroxidase 4 on cell proliferation, angiogenesis and cytokine production in hepatocellular carcinomaNataliya Rohr-Udilova, Eva Bauer, Gerald Timelthaler, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 13, 2021
Decreasing von Willebrand Factor Levels Upon Nonselective Beta Blocker Therapy Indicate a Decreased Risk of Further Decompensation, Acute-on-chronic Liver Failure, and DeathMathias Jachs, Lukas Hartl, Benedikt Simbrunner, et al.
Plos One|November 25, 2015
The Impact of PNPLA3 rs738409 SNP on Liver Fibrosis Progression, Portal Hypertension and Hepatic Steatosis in HIV/HCV CoinfectionBernhard Scheiner, Mattias Mandorfer, Philipp Schwabl, et al.
Pageof 47